Table 1.
ICM (n = 30) | DCM (n = 16) | |
---|---|---|
Age (years) | 54 ± 7 | 44 ± 13** |
Gender male (%) | 100 | 82 |
NYHA class | 3.5 ± 0.4 | 3.4 ± 0.5 |
BMI (kg/m2) | 28 ± 4 | 27 ± 6 |
Haemoglobin (mg/dL) | 14 ± 2 | 13 ± 2 |
Haematocrit (%) | 41 ± 5 | 39 ± 6 |
Total cholesterol (mg/dL) | 174 ± 56 | 127 ± 54* |
Prior hypertension (%) | 46 | 21 |
Prior smoking (%) | 86 | 58* |
EF (%) | 24 ± 11 | 21 ± 8 |
FS (%) | 17 ± 7 | 13 ± 8 |
LVESD (mm) | 53 ± 9 | 72 ± 9*** |
LVEDD (mm) | 63 ± 9 | 78 ± 9*** |
Left ventricle mass index (g/cm2) | 146 ± 37 | 210 ± 57** |
Duration of disease (months) | 44 ± 42 | 60 ± 52 |
Duration of disease from diagnosis of HF until heart transplant. BMI, body mass index; DCM, dilated cardiomyopathy; EF, ejection fraction; FS, fractional shortening; ICM, ischaemic cardiomyopathy; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; NYHA, New York Heart Association.
*P < 0.05.
**P < 0.01.
***P < 0.001.